Loading provider…
Loading provider…
Gynecologic Oncology Physician in Kansas City, MO
NPI: 1013172022Primary Practice Location
BELTON REGIONAL MEDICAL CENTER
17065 US Hwy 71 S, Belton, MO
Primary Employer
Midwest Oncology Associates LLC
HCAHealthcare.com
HQ Phone
Get D.O. Kristopher's Phone Numberphone_androidMobile
Get D.O. Kristopher's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMI State Medical License
MO State Medical License
PA State Medical License
KS State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 66 | 90 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 59 | 110 |
| 3 | 99213Established patient office or other outpatient visit, typically 15 minutes | 37 | 45 |
| 4 | 99205New patient office or other outpatient visit, typically 60 minutes | 33 | 33 |
| 5 | 58571Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope | 13 | 13 |
Review of Evidence Supporting the Arista™ Absorbable Powder Hemostat.
Authors: Kristopher Lybarger
Publication Date: 2023-11-22
Authors: Miller, Hunter A, Tran, Anh, LyBarger, K Shawn, Frieboes, Hermann B
Journal: Eur J Surg Oncol
Publication Date: 2023-12-01
Authors: Rebecca Arend, Haider Mahdi, Lisa Barroilhet, Linda Duska, Howard Goodman, Adam Elnaggar, Erika Hamilton, Cesar Castro
Journal: Gynecol Oncol
Publication Date: 2023-03-29
Lead Sponsor: Imunon
Intervention / Treatment: DRUG: Carboplatin, DRUG: Paclitaxel, BIOLOGICAL: IMNN-001
Lead Sponsor: Karyopharm Therapeutics Inc
Collaborators: Belgian Gynaecological Oncology Group, GOG Foundation, Israeli Society of Gynecologic Oncology, Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies, Spanish Research Group in Ovarian Cancer, The Central and Eastern European Gynecologic Oncology Group, North-Eastern German Society of Gynaecologic Oncology
Intervention / Treatment: DRUG: Selinexor, DRUG: Matching placebo for selinexor
Lead Sponsor: AbbVie
Collaborators: Gynecologic Oncology Group, European Network of Gynaecological Oncological Trial Groups (ENGOT)
Intervention / Treatment: DRUG: Paclitaxel, DRUG: Topotecan, DRUG: Mirvetuximab Soravtansine, DRUG: Pegylated liposomal doxorubicin